Home/Investors/Boyu Capital Boyu Capital
Biotech Investor · 14 portfolio companies
Portfolio Companies
| Company | Stage | Valuation | Focus |
|---|
| Innovent Biologics | Commercial | $151.5B | Oncology, Metabolic Disorders |
| Edge Medical | commercial | — | Surgery |
| Ocumension Therapeutics | phase-2 | — | Ophthalmology |
| Lepu Biopharma | phase-2 | — | Oncology, Immunology |
| CirCode Biomed | phase-1 | — | Infectious Disease, Oncology |
| CStone Pharmaceuticals | commercial | — | Oncology, Immunology |
| Antengene | commercial | — | Oncology, Immunology |
| Hexaell Biotech | phase-2 | — | Regenerative Medicine, Oncology |
| Innolake Biopharm | phase-3 | — | Oncology, Immunology |
| Fapon Biopharma | platform | — | Infectious Disease, Oncology |
| Sintaho Pharmaceutical | phase-2 | — | Oncology, Immunology |
| Keymed Biosciences | phase-2 | — | Oncology, Immunology |
| InnoCare | commercial | — | Oncology, Immunology |
| CSR Biotech | phase-2 | — | Oncology, Immunology |